6th International Cancer Study & Therapy Conference is going to be held during April 29-30, 2020 at Chicago, USA. Cancer Science-2020 is an initiative to unite the diverse researchers and business communities working in the field of cancer under one roof to understand the underlying biological procedures, current treatments which can be amended to increase effectiveness, precision, survivability and quality of life in cancer patients. Cancer is a leading cause of death worldwide. It is not a single disease to combat. Hence, there is a need for inter-disciplinary search globally: on how cancers develop, how to detect cancers at an early stage, how to design new anti-cancer therapies with greater efficiency, how to evaluate cancer risk and how to even prevent cancer from arising.
Cancer Science-2020 conference provides a platform for cancer researchers, clinicians, oncologists, academicians and young scientists from all over the world to fuel the development of targeted therapies. The conference will help to accelerate our understanding of cancer biology, development of new treatments to improve the standards in oncology practice.
Cancer Science-2020 conference includes plenary lectures, keynote lectures and short courses by eminent personalities from around the world. In addition to contributed papers, we also have oral presentations and poster presentations. This International Cancer Conference will help participants to learn the fundamentals of cancer science and to develop new skills necessary to envision and design cutting-edge cancer research projects that can contribute to high impact cancer research and cancer care.
"I would like to thank you for the excellent organization of the conference. Thank you for your cooperation & waiting for your upcoming conferences."
"The conference was successfully organized by the organizers, thanks for providing us with a platform for academic exchange. We also sincerely thank you and other organizers for your concern and help during the conference."
"My congratulations for all your very useful clinical-scientific activities, awaiting for more collaboration in the future."